WORLD
Seoul hospital to conduct clinical trial for Inovio's COVID-19 DNA vaccine candidate
WORLD

Seoul hospital to conduct clinical trial for Inovio's COVID-19 DNA vaccine candidate

Published: June 4, 2020  |  1 min read, 192 words
WRITTEN BY
Your review will affect the following:
> >[Gettyimages Bank]SEOUL -- The safety and efficacy of IN0-4800, a COVID-19 DNA vaccine candidate developed by Inovio Pharmaceuticals, an American biotechnology company, will be checked in clinical trials by a prominent state hospital in South Korea. Clinical trials will begin this month.The International Vaccine Institute (IVI) won approval from the Ministry of Food and Drug Safety, a public health watchdog, for Phase 1 and 2 trials in South Korea. Under a contract with the institute, INO-4800 will be administered to 40 adults to verify safety. Seoul National University Hospital will... READ MORE
CRITIC
N/A
N/Ano rating
Critic Reviews: N/A
We calculate ratings after a minimum of three reviews.
USER
N/A
N/Ano rating
User Reviews: N/A
We calculate ratings after a minimum of three reviews.
TOP REVIEWS
There are no reviews yet.

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.